No evidence ibuprofen bad for COVID-19 patients -Nurofen-maker - (London South East via NewsPoints Desk)

  • Reckitt Benckiser said it was not aware of any evidence that ibuprofen adversely impacts patients suffering from COVID-19, as reported by London South East.

  • The company produces the nonsteroidal anti-inflammatory drug Nurofen, which has ibuprofen as an active ingredient, and is indicated to treat pain and inflammation and to reduce fever.

  • The statement follows recent remarks by France's health minister, who said "the taking of anti-inflammatories [ibuprofen, cortisone…] could be a factor in aggravating the infection."

  • Olivier Véran also advised that "in case of fever, take paracetamol. If you are already taking anti-inflammatory drugs, ask your doctor's advice."

  • Reckitt Benckiser said it "has neither received new safety information nor been involved in the evaluation of any adverse events regarding the use of ibuprofen in COVID-19."

  • It added that "appropriate use of ibuprofen and paracetamol is still currently being recommended by most European health authorities as part of the symptomatic treatment of COVID-19."

To read more NewsPoints articles, click here.